C

Celldex Therapeutics

D

CLDX

USD

-0.72

(-1.7217%)

Market Closed

27,282.00

حجم التداول

-2.5

الربح لكل سهم

-

العائد الربحي

-14.945455

P/E

2,724,420,195.60

حجم السوق

اليوم

-1.7217%

1 اسبوع

-1.481%

1 شهر

15.840%

6 اشهر

1.507%

12 اشهر

54.395%

بداية السنة

3.709%

كل الوقت

0%

أصول ذات صلة

Title:
Celldex Therapeutics

Sector:

Healthcare

Industry:

Biotechnology

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا